Bills › 90th General Assembly
Relating to insurance coverage for biomarker testing
Sponsored by the House Commerce Committee
Topics:State budgetMedicaid
Where it is now
- Done: IntroducedJanuary 25, 2024
- Done: SubcommitteeJanuary 31, 2024
- Done: House committeeFebruary 8, 2024
- Done: Passes the HouseMarch 27, 202496–1
- Skipped: Senate committeeSkipped
- Done: Passes the SenateApril 9, 202446–0
- Done: To the GovernorApril 23, 2024
- Done: Signed into lawMay 1, 2024
Became HF 2668 → Its progress continues under the new number. Go to HF 2668 What’s a funnel?
What’s in it
This bill relates to health insurance coverage for biomarker testing. The bill defines “biomarker testing” as an analysis of an individual’s tissue, blood, or other biospecimen for the presence of a biomarker. “Biomarker” is also defined in the bill. The bill requires a health carrier that offers individual, group, or small group contracts, policies, or plans in this state that provide for third-party payment or prepayment of health or medical expenses to offer coverage for biomarker testing for purposes of diagnosing, treating, appropriately managing, or monitoring a disease or condition in a covered person when the test has demonstrated clinical utility as detailed in the bill.
Read the full explanation
“Clinical utility” is defined in the bill. Coverage shall be provided in a manner which limits disruptions in a person’s care. The bill requires a health carrier to provide a process on its internet site for a person and the person’s health care professional to seek an exception to coverage required under the bill. The bill applies to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2025, by the third-party payment providers enumerated in the bill. The bill specifies the types of specialized health-related insurance which are not subject to the bill’s coverage requirements. The bill applies to the medical assistance program under Code chapter 249A, the healthy and well kids in Iowa (Hawki) program under Code chapter 514I, and a managed care organization acting pursuant to a contract with the department of health and human services to administer either the medical assistance program or the Hawki program. The commissioner of insurance may adopt rules to administer the bill.
From the explanation printed with the bill as introduced, written by the Legislative Services Agency. Amendments adopted later aren’t reflected. Full bill text · What changed before it passed
House subcommittee
Named February 28, 2024. On March 12, 2024 it recommended passage. Vote Total: 2-0.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Fiscal note
Cost: up to $880,000 Compare with other bills
House File 2668 is estimated to increase costs to the State by approximately $86,000 in FY 2025 and $171,000 annually beginning in FY 2026. Data to estimate potential cost savings is not currently available; therefore, potential cost savings as a result of the Bill are not included.
- Final Fiscal Note — Biomarker Testing, Health Insurance · April 29, 2024
- Biomarker Testing, Health Insurance · March 20, 2024
- Health Insurance Coverage, Biomarker Testing · February 28, 2024
- Biomarker Testing, Health Insurance · February 21, 2024
Nonpartisan cost estimates from the Legislative Services Agency’s Fiscal Services Division. The newest is first. Reading a fiscal note
Iowa Code it changes
Creates§514C.36
Read from the bill as introduced. Each links to every bill touching that chapter of the Iowa Code. How the Code works
Lobbying
19 for · 0 against · 28 undecided · Who →
Family tree
Where this legislation came from and where it went: earlier tries, the versions it moved through this Assembly, and later bills built on it.
Earlier and later bills are matched by wording or an identical title; check the text to be sure it’s the same idea.